UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014191
Receipt number R000016526
Scientific Title Effect of RELVAR on asthma COPD overlap syndrome
Date of disclosure of the study information 2014/06/14
Last modified on 2014/12/10 17:57:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of RELVAR on asthma COPD overlap syndrome

Acronym

Effect of RELVAR on ACOS

Scientific Title

Effect of RELVAR on asthma COPD overlap syndrome

Scientific Title:Acronym

Effect of RELVAR on ACOS

Region

Japan


Condition

Condition

Asthma COPD overlap syndrome

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the clinical effect of Relvar for asthma COPD overlap syndrome

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Symptoms evaluated bu QOL quastionare

Key secondary outcomes

Respiratory function tests


Base

Study type


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treatment by Relvar

Interventions/Control_2

Treatment by Adoair

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

asthma COPD overlap syndrome

Key exclusion criteria

without active infection

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihisa Ishiura

Organization

Toyama City Hospital

Division name

Respiratory Medicine

Zip code


Address

2-1 Imaizumihokubumachi, Toyama City, Toyama Japan

TEL

+81-76-422-1112

Email

ishiura@tch.toyama.toyama.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihisa Ishiura

Organization

Toyama City Hospital

Division name

Respiratory Medicine

Zip code


Address

2-1 Imaizumihokubumachi, Toyama City, Toyama Japan

TEL

+81-76-422-1112

Homepage URL


Email

ishiura@tch.toyama.toyama.jp


Sponsor or person

Institute

Respiratory Medicine, Toyama City Hospital

Institute

Department

Personal name



Funding Source

Organization

Respiratory Medicine, Toyama City Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

富山市民病院呼吸器内科


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 14 Day

Last follow-up date

2014 Year 09 Month 30 Day

Date of closure to data entry

2014 Year 09 Month 30 Day

Date trial data considered complete

2014 Year 09 Month 30 Day

Date analysis concluded

2014 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 06 Day

Last modified on

2014 Year 12 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016526


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name